期刊
SIGNAL TRANSDUCTION AND TARGETED THERAPY
卷 7, 期 1, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41392-022-00889-0
关键词
-
资金
- National Natural Science Foundation of China [82022052, 82173128, 81930065, 82073377, 81772587]
- Natural Science Foundation of Guangdong Province [2018B030306049, 2021A1515012439]
- Science and Technology Program of Guangdong [2019B020227002]
- Science and Technology Program of Guangzhou [201904020046]
- CAMS Innovation Fund for Medical Sciences (CIFMS) [2019-I2M-5-036]
This study reveals the role and regulation mechanism of cysteine desulfurase (NFS1) in the sensitivity of colorectal cancer cells to oxaliplatin. Loss of NFS1 enhances the sensitivity of colorectal cancer cells to oxaliplatin and triggers PANoptosis by increasing intracellular levels of reactive oxygen species (ROS). In addition, high expression of NFS1 is associated with poor survival and chemoresistance in patients with colorectal cancer.
Metabolic enzymes have an indispensable role in metabolic reprogramming, and their aberrant expression or activity has been associated with chemosensitivity. Hence, targeting metabolic enzymes remains an attractive approach for treating tumors. However, the influence and regulation of cysteine desulfurase (NFS1), a rate-limiting enzyme in iron-sulfur (Fe-S) cluster biogenesis, in colorectal cancer (CRC) remain elusive. Here, using an in vivo metabolic enzyme gene-based clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 library screen, we revealed that loss of NFS1 significantly enhanced the sensitivity of CRC cells to oxaliplatin. In vitro and in vivo results showed that NFS1 deficiency synergizing with oxaliplatin triggered PANoptosis (apoptosis, necroptosis, pyroptosis, and ferroptosis) by increasing the intracellular levels of reactive oxygen species (ROS). Furthermore, oxaliplatin-based oxidative stress enhanced the phosphorylation level of serine residues of NFS1, which prevented PANoptosis in an S293 phosphorylation-dependent manner during oxaliplatin treatment. In addition, high expression of NFS1, transcriptionally regulated by MYC, was found in tumor tissues and was associated with poor survival and hyposensitivity to chemotherapy in patients with CRC. Overall, the findings of this study provided insights into the underlying mechanisms of NFS1 in oxaliplatin sensitivity and identified NFS1 inhibition as a promising strategy for improving the outcome of platinum-based chemotherapy in the treatment of CRC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据